Compare Domino's Pizza, Inc. (DPZ) vs Globus Medical Inc. Class A Common Stock (GMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Domino's Pizza, Inc. vs Globus Medical Inc. Class A Common Stock — how do they compare? Domino's Pizza, Inc. trades at $298.17 (market cap $9.73B), while Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B). The key difference: Domino's Pizza, Inc. and Globus Medical Inc. Class A Common Stock are close in size by market cap, and Domino's Pizza, Inc. pays a 2.69% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Domino's Pizza, Inc. for 106 Days and Globus Medical Inc. Class A Common Stock for 0 Days on average.
| DPZ | GMED | |
|---|---|---|
Market Cap | $9.73B | $10.25B |
Volume | 1,426,037 | 1,059,528 |
Sector | Consumer Cyclical | Health |
52-Week High | $438.42 | $96.82 |
52-Week Low | $282.89 | $58.33 |
Typical Hold Time | 106 Days | 0 Days |
Enterprise Value | $14.63B | $9.76B |
Dividend Yield | 2.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Domino's Pizza (DPZ) trades at $296.10, down 4.76% with recent earnings showing mixed results including a Q3 2026 beat. The stock maintains strong profitability with 12.03% net margin and trades at reasonable valuations (P/E 16.3, P/S 1.96). Technical indicators show a bullish overall signal despite near-term bearish pressure, with key support at $297. Recent news highlights dividend stability amid high debt levels and store closures in certain markets.
DPZ presents a compelling value opportunity with analyst consensus target of $361.44 (22% upside), though significant debt load and recent earnings misses warrant caution. The company's consistent revenue growth and strong cash flow generation support dividend sustainability, but competitive pressures and execution risks remain key watchpoints for investors.
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Domino's Pizza, Inc.
Domino's is a restaurant operator and franchiser with nearly 19,000 global stores across more than 90 international markets at the end of 2021. The firm generates revenue through the sales of pizza, wings, salads, and sandwiches at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's U.S. and Canadian restaurants. With roughly $17.7 billion in 2021 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Papa John's, and Little Caesars.
Read more on DPZ →About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →
